Microbiome modulates immunotherapy response in cutaneous squamous cell carcinoma
Experimental Dermatology · 2023
DOI: 10.1111/exd.14864 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2023. Verfasst von Anita Y Voigt und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Immunotherapy, Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
The gut microbiome is increasingly recognized to alter cancer risk, progression and response to treatments such as immunotherapy, especially in cutaneous melanoma. However, whether the microbiome influences immune checkpoint inhibitor (ICI) immunotherapy response to non‐melanoma skin cancer has not yet been defined. As squamous cell carcinomas (SCC) are in closest proximity to the skin microbiome, we hypothesized that the skin microbiome, which regulates cutaneous immunity, might affect SCC‐associated anti‐PD1 immunotherapy treatment response. We used ultraviolet radiation to induce SCC in SKH1 hairless mice. We then treated the mice with broad‐band antibiotics to deplete the microbiome, followed by colonisation by candidate skin and gut bacteria or persistent antibiotic treatment, all in parallel with ICI treatment. We longitudinally monitored skin and gut microbiome dynamics by 16S rRNA gene sequencing and tumour burden by periodic tumour measurements and histologic assessment. Our study revealed that antibiotics‐induced abrogation of the microbiome reduced the tumour burden, suggesting a functional role of the microbiome in non‐melanoma skin cancer therapy response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
- The Jackson Laboratory, Bar Harbor, Maine, USA.
- Departments of Anatomic Pathology and Tumor Biology, Moffitt Cancer Center, Florida, USA.
ORCID-Profile: Anita Y Voigt, Andrew Walter, Timothy H Young, John P Graham, Bruna M Batista Bittencourt, Alvaro de Mingo Pulido, Karol Prieto, Kenneth Y Tsai, John P Sundberg, Julia Oh
Förderung
- NIAMS NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
- NINDS NIH HHS
- NIGMS NIH HHS
- American Cancer Society
- LEO Pharma Research Foundation
- National Institutes of Health
Zitieren
APA
Voigt, A. Y., Walter, A., Young, T. H., Graham, J. P., Batista Bittencourt, B. M., de Mingo Pulido, A., Prieto, K., Tsai, K. Y., Sundberg, J. P., & Oh, J. (2023). Microbiome modulates immunotherapy response in cutaneous squamous cell carcinoma. Experimental Dermatology. https://doi.org/10.1111/exd.14864
Vancouver
Voigt AY, Walter A, Young TH, Graham JP, Batista Bittencourt BM, de Mingo Pulido A, et al. Microbiome modulates immunotherapy response in cutaneous squamous cell carcinoma. Experimental Dermatology. 2023. doi:10.1111/exd.14864
BibTeX
@article{Voigt2023,
author = {Voigt, Anita Y and Walter, Andrew and Young, Timothy H and Graham, John P and Batista Bittencourt, Bruna M and de Mingo Pulido, Alvaro and Prieto, Karol and Tsai, Kenneth Y and Sundberg, John P and Oh, Julia},
title = {Microbiome modulates immunotherapy response in cutaneous squamous cell carcinoma},
journal = {Experimental Dermatology},
year = {2023},
doi = {10.1111/exd.14864}
}
EUVIMED